Cardiovascular Disease and Mortality in Adults Aged ≥60 Years According to Recommendations by the American College of Cardiology/American Heart Association and American College of Physicians/American Academy of Family Physicians
暂无分享,去创建一个
Byron C. Jaeger | P. Whelton | G. Howard | M. Sims | P. Muntner | D. Clark | D. Shimbo | G. Ogedegbe | A. Bress | T. Plante | J. Booth | M. Supiano | D. E. Anstey | D. L. Long | M. Butler | J. Kalinowski | John N. Booth
[1] Ngoi Hui Chien. Masked , 2021, New Writing.
[2] David M. Reboussin,et al. Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines , 2018, Hypertension.
[3] Jackson T. Wright,et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Journal of the American College of Cardiology.
[4] K. Sink,et al. Syncope, Hypotension, and Falls in the Treatment of Hypertension: Results from the Randomized Clinical Systolic Blood Pressure Intervention Trial , 2018, Journal of the American Geriatrics Society.
[5] T. Wilt,et al. Hypertension Limbo: Balancing Benefits, Harms, and Patient Preferences Before We Lower the Bar on Blood Pressure , 2018, Annals of Internal Medicine.
[6] R. Brook,et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Journal of the American Society of Hypertension : JASH.
[7] D. Reboussin,et al. Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Journal of the American College of Cardiology.
[8] Anna C. Porter,et al. Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT). , 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[9] Sanjay Basu,et al. Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials , 2017, PLoS medicine.
[10] T. Wilt,et al. Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline From the American College of Physicians and the American Academy of Family Physicians , 2017, Annals of Internal Medicine.
[11] G. Lippi,et al. Statins for Primary Prevention of Cardiovascular Disease. , 2017, Trends in pharmacological sciences.
[12] A. Viera,et al. Masked Hypertension and Incident Clinic Hypertension Among Blacks in the Jackson Heart Study , 2016, Hypertension.
[13] Lenore J Launer,et al. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial. , 2016, JAMA.
[14] Kirsten Bibbins-Domingo,et al. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement. , 2016, Annals of internal medicine.
[15] C. Escobar Cervantes,et al. [A randomized trial of intensive versus standard blood pressure control]. , 2016, Semergen.
[16] E. Fox,et al. Association between 24-hour blood pressure variability and chronic kidney disease: a cross-sectional analysis of African Americans participating in the Jackson heart study , 2015, BMC Nephrology.
[17] M. Woodward,et al. Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data , 2014, The Lancet.
[18] Mary Cushman,et al. Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations. , 2014, JAMA.
[19] Judith S. Hochman,et al. Reprint: 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk. , 2013, Journal of the American Pharmacists Association : JAPhA.
[20] C. Lewis,et al. Association of race and sex with risk of incident acute coronary heart disease events. , 2012, JAMA.
[21] C. Burchfiel,et al. Diabetes, Impaired Glucose Tolerance, and Metabolic Biomarkers in Individuals with Normal Glucose Tolerance are Inversely Associated with Lung Function: The Jackson Heart Study , 2011, Lung.
[22] C. Moy,et al. Disparities in stroke incidence contributing to disparities in stroke mortality , 2011, Annals of neurology.
[23] J. Deckers,et al. Statins for primary prevention of cardiovascular disease , 2011, BMJ : British Medical Journal.
[24] Daniel Levy,et al. Relationships of BMI to Cardiovascular Risk Factors Differ by Ethnicity , 2010, Obesity.
[25] C. Schmid,et al. A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.
[26] C. Moy,et al. The Reasons for Geographic and Racial Differences in Stroke Study: Objectives and Design , 2005, Neuroepidemiology.
[27] W. Rosamond,et al. Cardiovascular disease event classification in the Jackson Heart Study: methods and procedures. , 2005, Ethnicity & disease.
[28] Daniel W. Jones,et al. Toward resolution of cardiovascular health disparities in African Americans: design and methods of the Jackson Heart Study. , 2005, Ethnicity & disease.
[29] Michael Pignone,et al. Physicians' ability to predict the risk of coronary heart disease , 2003, BMC health services research.
[30] Robert Gray,et al. A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .
[31] M. Mayo-Smith,et al. Differences in Generalists' and Cardiologists' Perceptions of Cardiovascular Risk and the Outcomes of Preventive Therapy in Cardiovascular Disease , 1996, Annals of Internal Medicine.
[32] M. Abrahamowicz,et al. Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study , 1995, BMJ.